合成血管移植物作为占位性瘤床囊肿的新治疗选择
本文报告2010年至2020年间4例胶质瘤切除后高压瘤床囊肿患者,通过将合成带环血管移植物植入裂隙阀内治疗。术后所有患者瘤床囊肿均消退,无与植入物相关并发症,无翻修生存分别为10、12、53和126个月。作者认为该方法安全有效,是治疗高压瘤床囊肿的新选择。
要点
- 胶质瘤切除后高压瘤床囊肿可能与裂隙阀形成有关。
- 4例患者植入合成带环血管移植物后囊肿均消退。
- 无植入物相关并发症,无翻修生存10至126个月。
核心结论
- 使用合成血管移植物支撑裂隙阀是治疗高压瘤床囊肿安全有效的新方法。
研究设计与样本
- 2010年至2020年间对4例胶质瘤切除后高压瘤床囊肿患者行合成带环血管移植物植入术。
主要发现
- 术后所有患者瘤床囊肿均消退。
- 无患者出现与植入血管移植物相关的并发症。
- 无翻修生存分别为10、12、53和126个月。
临床怎么用
- 作者认为合成血管移植物支撑裂隙阀是治疗高压瘤床囊肿安全有效的新选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Several authors have reported the formation of slit valves as the underlying pathomechanism of space-occupying tumor bed cysts. Iatrogenic slit valves following the resection of high-grade gliomas have been linked to certain risk factors such as intraoperative opening of the ventricles and attempts to seal these. The best therapeutic management of such cystic lesions remains elusive. Several treatment options such as cyst fenestration or cystoperitoneal shunting have been employed but remain associated with high rates of recurrence. With the given complications of the above-described treatment options, the objective was to devise a new therapy option that is safe and effective and treats the slit valve itself rather than its symptoms. METHODS: Between the years of 2010 and 2020, we successfully treated four patients with high-pressure tumor bed cysts following glioma resection by implantation of synthetic ringed vascular grafts into the slit valve. RESULTS: Postoperatively, the tumor bed cysts were regressive in all patients. Moreover, none of the treatment patients developed any complications associated with the implanted vascular grafts. Revision-free survival was 10, 12, 53, and 126 months, respectively. CONCLUSION: The use of synthetic vascular grafts as a means of stenting slit valves is a safe and effective novel treatment option for high-pressure tumor bed cysts.
引用
- Schieferdecker S, Beez T, Rapp M, et al. Synthetic vascular grafts as a new treatment option for space-occupying tumor bed cysts. Acta Neurochir (Wien). 2022. PMID: 35076758. doi:10.1007/s00701-022-05123-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。